about
Selective noradrenaline reuptake inhibitors for schizophreniaRelationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment.Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitorDuloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial.Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Adjunctive use of reboxetine in schizophrenia.
@en
Adjunctive use of reboxetine in schizophrenia.
@nl
type
label
Adjunctive use of reboxetine in schizophrenia.
@en
Adjunctive use of reboxetine in schizophrenia.
@nl
prefLabel
Adjunctive use of reboxetine in schizophrenia.
@en
Adjunctive use of reboxetine in schizophrenia.
@nl
P2093
P1433
P1476
Adjunctive use of reboxetine in schizophrenia.
@en
P2093
Dieter Naber
Falk Kiefer
Josef Arlt
Klaus Wiedemann
Mildred Schick
Thomas J Raedler
P304
P356
10.1016/J.EURPSY.2004.06.017
P407
P50
P577
2004-09-01T00:00:00Z